Feasibility of overnight closed-loop therapy in young children with type 1 diabetes aged 3–6 years: comparison between diluted and standard insulin strength-Reference-Cited by-同舟云学术

Feasibility of overnight closed-loop therapy in young children with type 1 diabetes aged 3–6 years: comparison between diluted and standard insulin strength

Published:2014-12 Issue:1 Volume:2 Page:e000040
ISSN:2052-4897
Container-title:BMJ Open Diabetes Research & Care
language:en
Short-container-title:BMJ Open Diab Res Care

Author:

Elleri Daniela,Allen Janet M,Tauschmann Martin,El-Khairi Ranna,Benitez-Aguirre Paul,Acerini Carlo L,Dunger David B,Hovorka Roman

Publisher

BMJ

Subject

Endocrinology, Diabetes and Metabolism

Reference38 articles.

1. Closed-loop insulin delivery for treatment of type 1 diabetes;Elleri;BMC Med,2011

2. Nocturnal glucose control with an artificial pancreas at a diabetes camp;Phillip;N Engl J Med,2013

3. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas;Weinzimer;Diabetes Care,2008

4. Closed-loop basal insulin delivery over 36 hours in adolescents with type 1 diabetes: randomized clinical trial;Elleri;Diabetes Care,2013

5. Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial;Hovorka;Lancet,2010

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ISPAD Clinical Practice Consensus Guidelines 2022: Managing diabetes in preschoolers;Pediatric Diabetes;2022-12

2. ISPAD Clinical Practice Consensus Guidelines 2022: Insulin treatment in children and adolescents with diabetes;Pediatric Diabetes;2022-12

3. ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes technologies: Insulin delivery;Pediatric Diabetes;2022-12

4. Automated insulin delivery: benefits, challenges, and recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association;Diabetologia;2022-10-06

5. Automated Insulin Delivery: Benefits, Challenges, and Recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association;Diabetes Care;2022-10-06